« Home « Kết quả tìm kiếm

Lung disease

Tìm thấy 20+ kết quả cho từ khóa "Lung disease"

Mortality rate in rheumatoid arthritis-related interstitial lung disease: The role of radiographic patterns

tailieu.vn

Usual interstitial pneumonia in rheumatoid arthritis‑associated interstitial lung disease. tive tissue disease related fibrotic lung disease: high resolution computed tomographic and pulmonary function indices as prognostic determi‑. Rheumatoid arthritis‑related interstitial lung disease (RA‑ILD): methotrexate and the severity of lung disease are asso‑. Risk factors for progression and prognosis of rheumatoid arthritis‑associated interstitial lung disease:.

Evaluation of the effects of dexmedetomidine infusion on oxygenation and lung mechanics in morbidly obese patients with restrictive lung disease

tailieu.vn

Evaluation of the effects of. dexmedetomidine infusion on oxygenation and lung mechanics in morbidly obese. patients with restrictive lung disease. Background: Dexmedetomidine infusion improves oxygenation and lung mechanics in patients with chronic obstructive lung disease. however, its effect in patients with restrictive lung disease has not been thoroughly investigated yet.

Interstitial lung disease is a dominant feature in patients with circulating myositis-specifc antibodies

tailieu.vn

Clinical and pathological findings of interstitial lung disease patients with anti-aminoacyl-tRNA synthetase autoantibodies.. Interstitial lung disease, a common manifestation of newly diagnosed polymyositis and dermatomyositis. Interstitial lung disease in polymyositis and dermatomyositis: longitudi- nal evaluation by pulmonary function and radiology. Anti-Jo-1 antibody: a marker for myositis with interstitial lung disease.

Cyclophosphamide for interstitial lung disease-associated acute respiratory failure: Mortality, clinical response and radiological characteristics

tailieu.vn

The greater proportion of GGOs might be associated with more widespread Table 2 In-hospital mortality of interstitial lung disease patients. with acute respiratory failure treated with cyclophosphamide. CTD-ILD, connective tissue disease-associated interstitial lung disease.

Risk assessment in interstitial lung disease: The incremental prognostic value of cardiopulmonary ultrasound

tailieu.vn

Sonographic assessment of interstitial lung disease in patients with rheumatoid arthritis, systemic sclerosis and systemic lupus erythematosus. Assessment of the correIation between the severity of interstitial lung disease and clinical parameters by cardiopul‑. The prognostic value of the GAP model in chronic interstitial lung disease: the quest for a staging system

High intensity interval training versus moderate intensity continuous training for people with interstitial lung disease: Protocol for a randomised controlled trial

tailieu.vn

Quality of life and health status in interstitial lung diseases. Chronic cough in adults with interstitial lung disease. Treatment of fibrotic interstitial lung disease: current approaches and future directions.. Early diagnosis of fibrotic interstitial lung disease: challenges and opportunities. Progression of fibrosing intersti- tial lung disease. Pulmonary rehabilitation for inter- stitial lung disease. Dowman LM, McDonald CF, Hill CJ, Lee AL, Barker K, Boote C, et al.

Pre-existing interstitial lung disease is associated with onset of nivolumabinduced pneumonitis in patients with solid tumors: A retrospective analysis

tailieu.vn

The Efficacy and Safety of Chemotherapy in Patients With Nonsmall Cell Lung Cancer and Interstitial Lung Disease: A PRISMA-Compliant Bayesian Meta-Analysis and Systematic Review. Pre-existing interstitial lung disease as a risk factor for pneumonitis associated with ramucirumab and paclitaxel in patients with gastric cancer: the impact of usual interstitial pneumonia.. https://doi.org/10.1371/journal.pone.01 98886.. https://doi.org/10.1378/chest .

Reliability of histopathologic diagnosis of fbrotic interstitial lung disease: An international collaborative standardization project

tailieu.vn

Transcriptional regulatory model of fibrosis progression in the human lung. Han Q, Luo Q, Xie JX et al. In-hospital mor- tality after surgical lung biopsy for interstitial lung disease in the United States. van der Wel MJ, Klaver E, Duits LC, et al. Richeldi L, Scholand MB, Lynch DA et al

Prognostic value of radiological fndings indeterminate for UIP pattern and anterior upper lobe honeycomb-like lesion in chronic fbrosing interstitial lung disease associated with MPO-ANCA

tailieu.vn

Prognostic value of radiological findings indeterminate for UIP pattern and anterior upper lobe honeycomb-like lesion in chronic fibrosing interstitial lung disease associated with MPO-ANCA.

Exposure–safety analyses of nintedanib in patients with chronic fibrosing interstitial lung disease

tailieu.vn

Keywords: Nintedanib, Idiopathic pulmonary fibrosis, Systemic sclerosis-associated interstitial lung disease, Progressive fibrosing ILDs, Exposure–safety relationship, Liver enzyme elevation. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material.

IL-6 expression helps distinguish Castleman’s disease from IgG4-related disease in the lung

tailieu.vn

IL-6 expression helps distinguish Castleman’s disease from IgG4-related disease in the lung. Background: It is difficult to distinguish between multicentric Castleman’s disease (MCD) and IgG4-related lung disease (IgG4-LD), an IgG4-related disease (IgG4-RD) in the lung.. Methods: We focused on IL-6, which is elevated in MCD, to distinguish between MCD and IgG4-LD by RNAscope, a highly sensitive RNA in situ method. Six cases of MCD and four cases of IgG4-LD were selected..

Lung ultrasound for the diagnosis of cystic fbrosis pulmonary exacerbation

tailieu.vn

Progressive lung disease limits the survival of CF patients. Having a proper attitude towards the severity of CF lung disease and monitoring it over time is impor- tant in directing clinical care and predicting disease out- comes. Imaging provides information about the regional distribution of CF lung disease. therefore, pulmonary imaging studies are recommended for the follow-up of CF patients.

Repeated bronchoscopy in health and obstructive lung disease: Is the airway microbiome stable

tailieu.vn

There was no lung or airways disease in the medical history, or signs of such from the clinical examination, lung function tests or CT scans of the control subjects.. Protected bronchoalveolar lavage [2] was collected from the right middle lobe by instilling 2 × 50 mL of PSB (PBAL1 and PBAL2) within a sterile inner catheter placed in the work- ing channel, and extracted with the same sterile syringe through which the fluid was instilled.

Lung function, COPD and cognitive function: A multivariable and two sample Mendelian randomization study

tailieu.vn

Much research has focused on whether lung function and lung disease causes mild cognitive impair- ment (MCI) [39]. Normal cognitive function and MCI exist on a spectrum, but our study is unable to fully assess whether reduced lung function or lung disease causes MCI. Our results indicate that lung function alone does not causes lower cognition in general population.

Outcome and prognostic factors after lung transplantation for bronchiectasis other than cystic fibrosis

tailieu.vn

In conclusion, the long-term outcome in LTX recipients with the underlying disease of bronchiectasis other than CF, a representative of the suppurative lung disease in Japan, was comparable to those without bronchiectasis.. Although multivariate anal- ysis will be needed for the further understanding of risk factors for post-transplant outcomes, this study will be fundamental to future trials for individuals with bronchi- ectasis requiring LTX.. LTX: Lung transplant.

Chapter 054. Skin Manifestations of Internal Disease (Part 17)

tailieu.vn

The most common systemic signs and symptoms are arthralgias and/or arthritis, nephritis, and crampy abdominal pain, with asthma and chronic obstructive lung disease seen less often. Hypocomplementemia occurs in one- to two-thirds of patients, even in the idiopathic cases. Urticarial vasculitis can. also be seen in patients with hepatitis B and hepatitis C infections, serum sickness, and serum sickness–like illnesses.

Chapter 054. Skin Manifestations of Internal Disease (Part 9)

tailieu.vn

a Absence of melanocytes.. b Normal number of melanocytes.. c Platelet storage defect and restrictive lung disease secondary to deposits of ceroid-like material. one form due to mutations in β subunit of adaptor protein..

Secondary polycythemia in chronic obstructive pulmonary disease: Prevalence and risk factors

tailieu.vn

Third, DLCO may be helpful in the evaluation of COPD patients with polycythemia, in whom a low DLCO might prompt an evaluation of concomitant interstitial lung disease or pulmonary vascular disease if hypoxemia alone fails to justify the presence of polycythemia.. whereas, continuous or nocturnal LTOT use were protective against secondary polycythemia in COPD. Multivariable logistic regression on polycythemia in subjects without anemia. Multivariable logistic regression.

Serum S100 calcium-binding protein A4 as a novel predictive marker of acute exacerbation of interstitial pneumonia after surgery for lung cancer

tailieu.vn

Approximately 4–6% of resected specimens of lung cancer showed some types of intersti- tial lung disease (ILD) [3]. after lung resection for lung cancer has been improved;. however, the major cause of death is acute exacerbation (AE) of IP, and the reported incidence and rate of mor- tality among patients with non-small cell lung cancer and AE with IP range from 0 to 32% and from 0 to 42%, respectively [4–6].

Outcomes of adjunctive surgery for nontuberculous mycobacterial pulmonary disease

tailieu.vn

Diel R, Nienhaus A, Ringshausen FC et al. ventions against mycobacterium avium complex pulmonary disease: a systematic review. Kwak N, Dalcolmo MP, Daley CL et al. gery for mycobacterium avium complex lung disease in the clarithromy‑. Watanabe M, Hasegawa N, Ishizaka A et al. Kang HK, Park HY, Kim D et al. Asakura T, Hayakawa N, Hasegawa N et al. nary resection for nontuberculous mycobacterial pulmonary disease. Aznar ML, Zubrinic M, Siemienowicz M et al. Fukushima K, Miki M, Matsumoto Y et al.